Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients

Lung Cancer

Volumn 67, Issue 1, 2010, Pages 93-100

  Pan, Szu Hua ^a   Chao, Yu Chih ^a   Chen, Hsuan Yu ^b   Hung, Pei Fang ^a   Lin, Pei Ying ^c   Lin, Chung Wu ^d   Chang, Yih Leong ^d   Wu, Chen Tu ^d   Lee, Yung Chie ^c   Yang, Shuenn Chen ^e   Hong, Tse Ming ^f,g   Yang, Pan Chyr ^c,e,g  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d School of Medicine   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

CRMP 1; Invasion enhancer; LCRMP 1; Metastasis; NSCLC; Prognostic biomarker

Indexed keywords

ANTIBODY; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 1; COMPLEMENTARY DNA; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; EXON; EXPRESSED SEQUENCE TAG; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOLECULAR WEIGHT; OVERALL SURVIVAL; PLASMID; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CLONING, MOLECULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; EXONS; EXPRESSED SEQUENCE TAGS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL;

EID: 71549136182     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.03.006     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics 2006. CA Cancer J Clin 56 (2006) 106-130
2. Hoffman P.C., Mauer A.M., and Vokes E.E. Lung cancer. Lancet 355 (2000) 479-485 [Erratum in Lancet 2000;355:1280]
3. Miller Y.E. Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 33 (2005) 216-223
4. Chamber A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 (2002) 563-572
5. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12 (2006) 895-904
6. Steeg P.S. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3 (2003) 55-63
7. Rosslenbroich V., Dai L., Baader S.L., Noegel A.A., Gieselmann V., and Kappler J. Collapsin response mediator protein-4 regulates F-actin bundling. Exp Cell Res 310 (2005) 434-444
8. Quinn C.C., Gray G.E., and Hockfield S. A family of proteins implicated in axon guidance and outgrowth. J Neurobiol 41 (1999) 158-164
9. Shih J.Y., Lee Y.C., Yang S.C., Hong T.M., Huang C.Y., and Yang P.C. Collapsin response mediator protein-1: a novel invasion-suppressor gene. Clin Exp Metastasis 20 (2003) 69-76
10. Li W., Herman R.K., and Shaw J.E. Analysis of the Caenorhabditis elegans axonal guidance and outgrowth gene unc-33. Genetics 132 (1992) 675-689
11. Goshima Y., Nakamura F., Strittmatter P., and Strittmatter S.M. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376 (1995) 509-514
12. Wang L.H., and Strittmatter S.M. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J Neurochem 69 (1997) 2261-2269
13. Fukada M., Watakabe I., Yuasa-Kawada J., Kawachi H., Kuroiwa A., Matsuda Y., et al. Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J Biol Chem 275 (2000) 37957-37965
14. Arimura N., Inagaki N., Chihara K., Menager C., Nakamura N., Amano M., et al. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem 275 (2000) 23973-23980
15. Leung T., Ng Y., Cheong A., Ng C.H., Tan I., Hall C., et al. p80 ROKalpha binding protein is a novel splice variant of CRMP-1 which associates with CRMP-2 and modulates RhoA-induced neuronal morphology. FEBS Lett 532 (2002) 445-449
16. Quinn C.C., Chen E., Kinjo T.G., Kelly G., Bell A.W., Elliott R.C., et al. TUC-4b, a novel TUC family variant, regulates neurite outgrowth and associates with vesicles in the growth cone. J Neurosci 23 (2003) 2815-2823
17. Yuasa-Kawada J., Suzuki R., Kano F., Ohkawara T., Murata M., and Noda M. Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. Eur J Neurosci 17 (2003) 2329-2343
18. Katano T., Mabuchi T., Okuda-Ashitaka E., Inagaki N., Kinumi T., and Ito S. Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. Proteomics 6 (2006) 6085-6094
19. Shih J.Y., Yang S.C., Hong T.M., Yuan A., Chen J.J., Yu C.J., et al. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J Natl Cancer Inst 93 (2001) 1392-1400
20. Chu Y.W., Yang P.C., Yang S.C., Shyu Y.C., Hendrix M.J., Wu R., et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17 (1997) 353-360
21. Hong T.M., Yang P.C., Peck K., Chen J.J., Yang S.C., Chen Y.C., et al. Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray. Am J Respir Cell Mol Biol 23 (2000) 355-363
22. Chen J.J., Peck K., Hong T.M., Yang S.C., Sher Y.P., Shih J.Y., et al. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61 (2001) 5223-5230
23. Sobin L., and Wittekind C. International Union Against Cancer (UICC): "TNM classification of malignant tumors". 6th ed. (2002), Wiley, New York
24. Chen H.Y., Yu S.L., Chen C.H., Chang G.C., Chen C.Y., Yuan A., et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356 (2007) 11-20
25. Yu S.L., Chen H.Y., Chang G.C., Chen C.Y., Chen H.W., Singh S., et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13 (2008) 48-57
26. Winton T., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597
27. Zheng Z., Chen T., Li X., Haura E., Sharma A., and Bepler G. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 356 (2007) 800-808
28. Marks J.L., Broderick S., Zhou Q., Chitale D., Li A.R., Zakowski M.F., et al. Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma. J Thorac Oncol 3 (2008) 111-116
29. Bepler G., Begum M., and Simon G.R. Molecular analysis-based treatment strategies for non-small cell lung cancer. Cancer Control 15 (2008) 130-139
30. Rosell R., Felip E., and Paz-Ares L. How could pharmacogenomics help improve patient survival?. Lung Cancer 57 Suppl. 2 (2007) S35-S41